Krystal Biotech buy Citigroup Inc.
Start price
27.02.24
/
50%
€152.00
Target price
27.02.25
€179.60
Performance (%)
8.39%
Price
05.08.24
€164.75
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ shows slight gains of 8.39%. This prediction currently runs until 27.02.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Krystal Biotech | -13.221% | -13.221% |
iShares Core DAX® | -5.585% | -6.284% |
iShares Nasdaq 100 | -7.241% | -13.117% |
iShares Nikkei 225® | -8.933% | -10.904% |
iShares S&P 500 | -6.148% | -7.562% |
Comments by Citigroup_Inc_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Citigroup Inc. from $160.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat